Theses

Personalized Medicine: Pharmacogenetic Testing in Drug Development and Clinical Practice
Frederieke van der Baan

Off-target effects of RAAS-inhibition:importance on renal outcomes in patients with diabetes
Yan Miao

Non-inferiority trials: methodological and regulatory challenges
Grace Wangge

Making better use of clinical trials
Gert van Valkenhoef

Innovations in Post-Marketing Safety Research
Guðrún Stefánsdóttir

The evaluation of drug regulation - Economic approaches into the valuation and evaluation of the drug regulatory framework
Jacoline Bouvy

Regulatory benefit-risk assessment
Arna Hrund Arnardottir

Methods to improve the efficiency of confirmatory clinical trials
Ruud Boessen

Ethical issues in postauthorization drug trials
Rosemarie Bernabe

Biopharmaceuticals as Challenges to the Regulatory System
Hans Ebbers

Marketing authorisation of new medicines in the EU: towards evidence-based improvement
Michelle Putzeist